Shenhai Gong1, Tian Lan2, Liyan Zeng3, Haihua Luo1, Xiaoyu Yang1, Na Li1, Xiaojiao Chen4, Zhanguo Liu5, Rui Li2, Sanda Win6, Shuwen Liu7, Hongwei Zhou4, Bernd Schnabl8, Yong Jiang9, Neil Kaplowitz6, Peng Chen10. 1. State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China; Department of Pathophysiology, Southern Medical University, Guangzhou, China. 2. Guangdong Pharmaceutical University, Guangzhou, China. 3. School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China. 4. State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China. 5. Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China. 6. University of Southern California Research Center for Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, USA. 7. State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China. 8. Department of Medicine, University of California San Diego, La Jolla, USA. 9. State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China; Department of Pathophysiology, Southern Medical University, Guangzhou, China. Electronic address: jiang48231@163.com. 10. State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China; Department of Pathophysiology, Southern Medical University, Guangzhou, China; Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Electronic address: perchen@smu.edu.cn.
Abstract
BACKGROUND & AIMS: Acetaminophen (APAP) induced hepatotoxicity is a leading cause of acute liver failure worldwide. It is well established that the liver damage induced by acetaminophen exhibits diurnal variation. However, the detailed mechanism for the hepatotoxic variation is not clear. Herein, we aimed to determine the relative contributions of gut microbiota in modulating the diurnal variation of hepatotoxicity induced by APAP. METHODS: Male Balb/C mice were treated with or without antibiotics and a single dose of orally administered APAP (300 mg/kg) at ZT0 (when the light is on-start of resting period) and ZT12 (when the light is off-start of active period). RESULTS: In agreement with previous findings, hepatic injury was markedly enhanced at ZT12 compared with ZT0. Interestingly, upon antibiotic treatment, ZT12 displayed a protective effect against APAP hepatotoxicity similar to ZT0. Moreover, mice that received the cecal content from ZT12 showed more severe liver damage than mice that received the cecal content from ZT0. 16S sequencing data revealed significant differences in the cecal content between ZT0 and ZT12 in the compositional level. Furthermore, metabolomic analysis showed that the gut microbial metabolites were also different between ZT0 and ZT12. Specifically, the level of 1-phenyl-1,2-propanedione (PPD) was significantly higher at ZT12 than ZT0. Treatment with PPD alone did not cause obvious liver damage. However, PPD synergistically enhanced APAP-induced hepatic injury in vivo and in vitro. Finally, we found Saccharomyces cerevisiae, which could reduce intestinal PPD levels, was able to markedly alleviate APAP-induced liver damage at ZT12. CONCLUSIONS: The gut microbial metabolite PPD was responsible, at least in part, for the diurnal variation of hepatotoxicity induced by APAP by decreasing glutathione levels. LAY SUMMARY: Acetaminophen (APAP) induced acute liver failure because of over dose is a leading public health problem. APAP-induced liver injury exhibits diurnal variation, specifically APAP causes more severe liver damage when taken at night compared with in the morning. Herein, we showed that gut microbial metabolite, 1-phenyl-1,2-propanedione is involved in the rhythmic hepatotoxicity induced by APAP, by depleting hepatic glutathione (an important antioxidant) levels. Our data suggest gut microbiota may be a potential target for reducing APAP-induced acute liver injury.
BACKGROUND & AIMS:Acetaminophen (APAP) induced hepatotoxicity is a leading cause of acute liver failure worldwide. It is well established that the liver damage induced by acetaminophen exhibits diurnal variation. However, the detailed mechanism for the hepatotoxic variation is not clear. Herein, we aimed to determine the relative contributions of gut microbiota in modulating the diurnal variation of hepatotoxicity induced by APAP. METHODS: Male Balb/C mice were treated with or without antibiotics and a single dose of orally administered APAP (300 mg/kg) at ZT0 (when the light is on-start of resting period) and ZT12 (when the light is off-start of active period). RESULTS: In agreement with previous findings, hepatic injury was markedly enhanced at ZT12 compared with ZT0. Interestingly, upon antibiotic treatment, ZT12 displayed a protective effect against APAPhepatotoxicity similar to ZT0. Moreover, mice that received the cecal content from ZT12 showed more severe liver damage than mice that received the cecal content from ZT0. 16S sequencing data revealed significant differences in the cecal content between ZT0 and ZT12 in the compositional level. Furthermore, metabolomic analysis showed that the gut microbial metabolites were also different between ZT0 and ZT12. Specifically, the level of 1-phenyl-1,2-propanedione (PPD) was significantly higher at ZT12 than ZT0. Treatment with PPD alone did not cause obvious liver damage. However, PPD synergistically enhanced APAP-induced hepatic injury in vivo and in vitro. Finally, we found Saccharomyces cerevisiae, which could reduce intestinal PPD levels, was able to markedly alleviate APAP-induced liver damage at ZT12. CONCLUSIONS: The gut microbial metabolite PPD was responsible, at least in part, for the diurnal variation of hepatotoxicity induced by APAP by decreasing glutathione levels. LAY SUMMARY:Acetaminophen (APAP) induced acute liver failure because of over dose is a leading public health problem. APAP-induced liver injury exhibits diurnal variation, specifically APAP causes more severe liver damage when taken at night compared with in the morning. Herein, we showed that gut microbial metabolite, 1-phenyl-1,2-propanedione is involved in the rhythmic hepatotoxicity induced by APAP, by depleting hepatic glutathione (an important antioxidant) levels. Our data suggest gut microbiota may be a potential target for reducing APAP-induced acute liver injury.
Authors: Sabine Wagnerberger; Astrid Spruss; Giridhar Kanuri; Carolin Stahl; Markus Schröder; Walter Vetter; Stephan C Bischoff; Ina Bergheim Journal: J Nutr Biochem Date: 2012-06-27 Impact factor: 6.048
Authors: Jill C Gregory; Jennifer A Buffa; Elin Org; Zeneng Wang; Bruce S Levison; Weifei Zhu; Matthew A Wagner; Brian J Bennett; Lin Li; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen Journal: J Biol Chem Date: 2014-12-30 Impact factor: 5.157
Authors: Jun Zhang; Robert W M Min; Khanh Le; Sheng Zhou; Mariam Aghajan; Tin A Than; Sanda Win; Neil Kaplowitz Journal: Cell Death Dis Date: 2017-06-29 Impact factor: 8.469
Authors: Anne van Rongen; Pyry A J Välitalo; Mariska Y M Peeters; Djamila Boerma; Fokko W Huisman; Bert van Ramshorst; Eric P A van Dongen; Johannes N van den Anker; Catherijne A J Knibbe Journal: Clin Pharmacokinet Date: 2016-07 Impact factor: 6.447